In our study, we aimed to measure the dose exposed by the fetus during three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT) treatment techniques in pregnant patients who had to undergo radiotherapy due to breast cancer with thermoluminescence dosimetry (TLD) and compare these measurements with treatment planning system (TPS).
2.5 mm- thick computed tomography (CT) images of Alderson Rando phantom device were taken for measurements. In order to compare the TPS and TLD readings in PTV, 60 TLDs were placed in the target volume in the Rando phantom. Twenty-four TLDs were placed in the 30th and 31st sections of the phantom, which is likely to be in the volumetric size of the first trimester of pregnancy which is also located 25.84 cm from the lower limit of the PTV. Six MV were used in seven different treatment techniques and the measurements were repeated 5 times for each technique and averaged.
Fetal doses for all treatment techniques in TPS were found as 0.00 cGy. However, TLD measurements were measured between 3.36 ± 0.19 cGy and 16.10 ± 2.04. In 3D-CRT treatment technique the fetus received the lowest dose. In addition, for plans made using the IMRT method, it is seen that the MSS-IMRT technique provides better fetal protection compared to the SW-IMRT technique.
The 3D-CRT should be the first priority for a pregnant patient who has to undergo left breast RT, but if the desired dose-volume histogram (DVH) cannot be obtained with 3D-CRT, 5 MSS-IMRT technique may be preferred.